NCT00834431View on ClinicalTrials.gov

Famciclovir 500 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

September 30, 2004

Study Completion Date

September 30, 2004

Conditions
Healthy
Interventions
DRUG

Famciclovir 500 mg Tablets

1 x 500 mg, single-dose fasting

DRUG

Famvir® 500 mg Tablets

1 x 500 mg, single-dose fasting

Trial Locations (2)

63301

Gateway Medical Research, Inc., Saint Charles

M1P2X4

Ba Research Co., Toronto

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00834431 - Famciclovir 500 mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter